Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason Aaron Freed, M.D.

Concepts (120)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Factor Xa120211680.820 Why?
Vitamin B 12 Deficiency120201120.800 Why?
Thrombotic Microangiopathies120201160.770 Why?
Blood Sedimentation120192380.720 Why?
Purpura120181310.700 Why?
Eosinophilia120204950.660 Why?
Giant Cell Arteritis120192410.600 Why?
Internship and Residency5202253220.580 Why?
Urate Oxidase12014340.550 Why?
Methemoglobinemia12014450.550 Why?
Referral and Consultation3202132960.500 Why?
Gout Suppressants120141570.480 Why?
Recombinant Proteins1202170600.420 Why?
Inpatients1202120500.410 Why?
Waldenstrom Macroglobulinemia120199930.400 Why?
Venous Thrombosis1201812240.380 Why?
Hospitals1202129300.360 Why?
Medical Oncology1201918820.350 Why?
Hospitalists220212750.330 Why?
Burnout, Professional320205590.270 Why?
Vermont12020920.220 Why?
Teaching Rounds220201940.210 Why?
Family Conflict12019980.190 Why?
Physicians3202040600.180 Why?
Lymphocyte Count120208040.180 Why?
African Americans1201451440.180 Why?
Kinesics12017130.170 Why?
Communication3202232370.170 Why?
Blood Coagulation Disorders120203290.170 Why?
Education, Medical, Graduate2202220990.170 Why?
Nonverbal Communication12017600.170 Why?
Psychological Theory120181740.160 Why?
Trauma Centers120218210.150 Why?
Teaching3202112130.150 Why?
Curriculum3202231140.140 Why?
Medicine120218010.140 Why?
Proto-Oncogene Proteins c-met220156030.130 Why?
Immunoglobulin M1201914940.130 Why?
Self Efficacy120186230.130 Why?
Personal Satisfaction120185540.130 Why?
Humans2620226866630.130 Why?
Diagnosis, Differential22020136030.130 Why?
Adenocarcinoma3201664500.130 Why?
Patient Care120195640.130 Why?
Mutagenesis, Insertional120166740.130 Why?
Heparin1202016790.120 Why?
Intelligence120189310.120 Why?
Learning2201815180.110 Why?
Vision Disorders120199780.110 Why?
Headache1201910630.110 Why?
Aged820201622710.110 Why?
Gene Amplification1201510940.110 Why?
Clinical Competence3202246320.110 Why?
Alternative Splicing1201511370.100 Why?
Venous Thromboembolism1202014290.090 Why?
Quinazolines1201614180.090 Why?
Fatal Outcome1201419390.090 Why?
Protein Kinase Inhibitors2201552520.090 Why?
Patient-Centered Care1201914210.090 Why?
Motivation1201818630.090 Why?
Lung Neoplasms32016120090.080 Why?
Palliative Care1202230930.080 Why?
Boston1202095340.080 Why?
C-Reactive Protein1201935690.080 Why?
Retrospective Studies52020673200.080 Why?
Adult620222114000.080 Why?
Biopsy1201968490.080 Why?
Students, Medical1201815870.080 Why?
Education, Medical1201816250.080 Why?
Receptor, erbB-21201622120.080 Why?
Pyrazoles1201519070.070 Why?
Pyridines1201528430.060 Why?
Predictive Value of Tests12019154070.060 Why?
Practice Guidelines as Topic1202076310.060 Why?
Delivery of Health Care1201944660.060 Why?
Cross-Sectional Studies12021216400.050 Why?
Faculty, Medical2202111360.050 Why?
Partial Thromboplastin Time120202050.050 Why?
Jurisprudence120191220.050 Why?
Male520203524650.050 Why?
Female620203754590.040 Why?
Receptor Protein-Tyrosine Kinases2201516160.040 Why?
United States22021655790.040 Why?
Feedback120207280.040 Why?
Middle Aged220202164680.040 Why?
Protein-Tyrosine Kinases2201524730.040 Why?
Antineoplastic Agents22015138980.040 Why?
Professional-Family Relations120194730.040 Why?
Anticoagulants2202041730.040 Why?
Peer Group120206300.030 Why?
Radiation-Sensitizing Agents120164080.030 Why?
Patient Care Planning120199510.030 Why?
Interdisciplinary Communication1201910070.030 Why?
Adolescent12020849570.030 Why?
Proto-Oncogene Proteins2201547160.030 Why?
Genomic Instability120156910.030 Why?
Treatment Outcome22015609910.030 Why?
Leadership1202012640.030 Why?
Mutation12015288480.030 Why?
Hemorrhage1202031490.020 Why?
Societies, Medical1202037150.020 Why?
Tumor Cells, Cultured1201668350.020 Why?
Parents1201930930.020 Why?
Physician-Patient Relations1201933400.020 Why?
Cell Survival1201562880.020 Why?
Phosphorylation1201588960.020 Why?
Molecular Targeted Therapy1201528840.020 Why?
Incidence12020204960.010 Why?
Reproducibility of Results12020193080.010 Why?
Neoplasm Staging12016112650.010 Why?
Survival Rate12016136060.010 Why?
Genotype12015130730.010 Why?
Genomics1201549210.010 Why?
Cell Line, Tumor12015172510.010 Why?
Cohort Studies12020387320.010 Why?
Prospective Studies12020490710.010 Why?
Prognosis12016289230.010 Why?
Follow-Up Studies12016397370.010 Why?
Risk Factors12020692780.010 Why?
Tomography, X-Ray Computed12015204090.010 Why?
Freed's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (120)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.